[Personal Care Insights] Cases of human harm in South Korean cosmetic trials double in four years

[Personal Care Insights] Cases of human harm in South Korean cosmetic trials double in four years

This article is originally posted by on Personal Care Insights' September 22, 2025 Article. To read the full feature, please visit the link below.

Cases of human harm in South Korean cosmetic trials double in four years
The reported cases of harm to participants in cosmetic human trials in South Korea are growing in tandem with the number of trials. While the K-beauty industry is booming, the government has received criticism for insufficient protection, and cases of severe skin irritation, rashes, and conjunctivitis have increased.  The South Korean Ministry of Food and Drug Safety (MFDS) oversees the cosmetics policy, but has reportedly acknowledged that it does not fully oversee the sector.  

Key takeaways

  • Cases of harm reported in human trials for K-beauty products have increased alongside the number of trials.
  • The Ministry of Food and Drug Safety oversees the cosmetics policy, but has reportedly acknowledged that it does not fully oversee the sector.
  • The number of participants in trials last year is estimated at 200,000, according to the data.

The reported cases of harm to participants in cosmetic human trials in South Korea are growing in tandem with the number of trials. While the K-beauty industry is booming, the government has received criticism for insufficient protection, and cases of severe skin irritation, rashes, and conjunctivitis have increased.  

The South Korean Ministry of Food and Drug Safety (MFDS) oversees the cosmetics policy, but has reportedly acknowledged that it does not fully oversee the sector.  

Last year, the ministry reported 39 side effects and compensation cases, more than double the 16 cases reported in 2020, according to data from the People Power Party (PPP) in South Korea.

“MFDS has neglected the safety of participants, who are the foundation of K-beauty’s growth. Institutions should be required to report adverse cases to the government. Only by protecting consumers and respecting participants’ rights can K-beauty grow without leaving scars,” says a representative from the PPP.

Human trials

According to the data, 21 institutions conducted 9,984 human trials last year. The number has doubled in four years, from 4,375 in 2020. The number of participants in trials last year is estimated at 200,000.

Korea Dermatology Research Institute was among the top human testing institutions last year, conducting 2,200 trials, and the P&K Skin Research Center conducted 1,717. Respectively, they accounted for 18.9% and 17.3% of all cases at the 21 institutions.

Human trials are conducted to ensure the safety and efficacy of products. The 21 institutions conducting trials are members of the Korean Association of Human Research Centers, which has 30 member companies.

However, not all 30 members submit records, and several institutions operate outside the partnerships. 

The publication K Beauty Science wrote that testing cosmetics on people is an indispensable part of K-beauty’s hidden credibility, which has led to its current status. It says that human application testing in K-beauty has emerged as a new business model. 

human testing cosmetics waterproof

Human trials are conducted to ensure the safety and efficacy of products. Steep increase in testing

According to The Korea Times, the number of cosmetics products registered in the country increased from 1.2 million in 2020 to 1.38 million in 2024. 

The publication states that the government prioritizes industry growth, over health concerns. 

Earlier this year, South Korea became the second-largest global cosmetics exporter, surpassing the US and trailing behind France. According to the Korea International Trade Association, the country exported US$3.61 billion of beauty products from January to April, edging the US with US$3.57 billion.

Tech for testing

Integrating AI in business operations is increasingly implemented in the cosmetics industry, especially in K-beauty. Trendier AI previously told us how beauty companies can tenfold the time they spend on marketing research and production, innovate new ingredients, and speed up consumer feedback using the emerging technology.  

Kei Chun, CEO and co-founder of the South Korea-based company, told us: “The K-beauty industry is all about speed and dynamism. [AI in the beauty industry] isn’t just about the future, but it’s already happening now. AI is being applied across the entire value chain.”

However, technology has also shown potential to replace unethical testing in cosmetics. A study published earlier this year demonstrated how human organ-on-a-chip technologies can potentially replace animal testing in cosmetics.

The researchers said that the technology can be used to evaluate personal care products for toxicity more ethically and with faster results than traditional cosmetics testing.

Read more

한국 탈모 관련 세그먼트에서 두피 앰플이 올리브영 추적 상품의 75%를 차지했다. trendier AI 올리브영 오젬픽 헤어 트렌드 리포트 표지.

글로벌 헤어케어 트렌드 2026 | 다섯 시장, 서로 다른 성장 공식

trendier AI가 2026년 상반기 5개 시장의 헤어케어 리뷰 데이터를 분석한 결과, 글로벌 헤어케어 시장은 하나의 방향으로 수렴하고 있지 않았습니다. 한국은 두피, 일본은 바이오테크 성분, 미국은 지속력, 영국은 손상 케어 성분, 독일은 확장되는 케어 루틴을 중심으로 시장이 형성되고 있습니다. 특히 한국의 탈모 관련 세그먼트에서는 두피 앰플이 올리브영에서 추적된 상품의 75%를

By Trendier AI
2026년 1월부터 6월까지 Sephora US 두피 케어의 포맷별 비중을 월별 누적 막대로 비교한 차트. 세럼이 전 기간 가장 큰 비중을 차지했으며, 우측 표에는 세럼 88개, 스크럽 23개, 젤 15개 등 주요 포맷별 상품 수와 증감, 평균 가격, 리뷰 수가 정리돼 있다.

두피 케어 리뷰 분석 2026 | Sephora US, 상품은 늘고 리뷰는 33% 감소

trendier AI가 Sephora US 두피 케어 데이터를 분석한 결과, 2026년 상반기 상품 수는 늘었지만 리뷰 수는 33% 감소했습니다. 상품 구성은 확대됐지만 리뷰는 줄었습니다. 같은 기간 두 지표가 서로 반대 방향으로 움직였습니다. 두피 케어 리뷰 분석: 상품은 늘고 리뷰는 줄었다 상품 수가 늘어나면 카테고리도 성장하고 있다고 해석하기 쉽습니다. 하지만 이번에는 리뷰

By Trendier AI